Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 1991
Effects of 17 beta-estradiol on calcitonin secretion and content in a human medullary thyroid carcinoma cell lineM Lazaretti-Castro, A Grauer, Y Mekonnen, et al.
Endocrinology|November 1, 1994
Differential effects of 1,25-dihydroxyvitamin D3 on cell proliferation and calcitonin gene expressionR Baier, A Grauer, M Lazaretti-Castro, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 17, 2009
New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumourK Frank-Raue, J Döhring, G Scheumann, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2AI Berndt, M Reuter, B Saller, et al.
The American Journal of Medicine|October 1, 1993
Formation of neutralizing antibodies after treatment with human calcitoninA Grauer, H H Reinel, S Lunghall, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative studyU Dörr, S Würstlin, K Frank-Raue, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 1, 1995
1,25-Dihydroxyvitamin D3 stimulates growth and inhibits calcitonin secretion in a human C cell carcinoma cell lineM Lazaretti-Castro, A Grauer, R Baier, et al.
Deutsche Medizinische Wochenschrift (1946)|September 26, 2003
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]K Frank-Raue, C Heimbach, S Rondot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potentialT M Behr, M Béhé, C Angerstein, et al.
Pageof 23